Global Infection Surveillance Solutions

Infection Surveillance Solutions Comprehensive Study by Type (Software, Services), Application (Hospitals, Long-term Care Facilities, Others(Clinics, and Ambulatory Surgical Centers)), Services (Product Support & Maintenance Services, Training & Consulting Services, Implementation Services), Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others), Software (On-premise, Web-based) Players and Region - Global Market Outlook to 2026

Infection Surveillance Solutions Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Infection Surveillance Solutions Market Scope
Infection surveillance is the ongoing systematic collection, analysis, and interpretation of healthcare-associated infections (HAIs) data essential for planning, implementation, and evaluation of public health practices. Proactively managing and controlling the spread of COVID-19 amongst the senior population is top of mind for healthcare providers and government agencies worldwide. To effectively understand and bring awareness to infections, care teams need an efficient way to review and access centralized case information and facilitate transparency in reporting of infection information across their facilities and communities.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Infection Surveillance Solutions market throughout the predicted period.

Becton, Dickinson and Company (United States), Premier Inc. (United States), Wolters Kluwer N.V. (Netherlands), Baxter International Inc. (United States), GOJO Industries, Inc. (United States), Atlas Medical Software (United States), Deb Group Ltd (United Kingdom), Hygreen Inc. (United States), PointClickCare (Canada) and Inovalon (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are TRUVEN Health Analytics (United States) and RL Solutions (Canada).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Infection Surveillance Solutions market by Type (Software and Services), by Application (Hospitals, Long-term Care Facilities and Others(Clinics, and Ambulatory Surgical Centers)) and Region with country level break-up.

On the basis of geography, the market of Infection Surveillance Solutions has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In April 2020, PointClickCare announced the release of its Infection Prevention and Control (IPC) solution, a clinical workflow and intelligence solution that helps Infection Preventionists and care teams perform ongoing resident surveillance focused on infection prevention., and In May 2020, Inovalon announced the launch of InfectionWatch™, an infection surveillance, and reporting solution that provides healthcare facilities with data-driven insights to empower real-time identification of infections demonstrating antibiotic resistance and virus outbreaks such as COVID-19.


Market Trend
  • Adaptation of Automation in Healthcare Facilities

Market Drivers
  • Increasing Incidence of Healthcare-Associated Infections (HAIs)
  • Changing Healthcare Scenario and Rising Automation

Opportunities
  • Cloud-Based Software Offers Significant Growth Opportunities
  • High Growth in Developing Counties Across APAC and Latin America

Restraints
  • High Cost of Software
  • Lack of Skilled IT Professionals in the Healthcare Industry

Challenges
  • Under Developed IT Infrastructure in Developing Countries


Key Target Audience
Infection Surveillance Software Providers, Hospitals and LTC Facilities, Research and Consulting Firms, Distributors of Infection Surveillance Software, Healthcare Institutions, Research Institutes and Potential Investors

Report Objectives / Segmentation Covered

By Type
  • Software
  • Services
By Application
  • Hospitals
  • Long-term Care Facilities
  • Others(Clinics, and Ambulatory Surgical Centers)
By Services
  • Product Support & Maintenance Services
  • Training & Consulting Services
  • Implementation Services

By Infection Type
  • Surgical Site Infections (SSI)
  • Blood Stream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Others

By Software
  • On-premise
  • Web-based

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Healthcare-Associated Infections (HAIs)
      • 3.2.2. Changing Healthcare Scenario and Rising Automation
    • 3.3. Market Challenges
      • 3.3.1. Under Developed IT Infrastructure in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Adaptation of Automation in Healthcare Facilities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Infection Surveillance Solutions, by Type, Application, Services, Infection Type, Software and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Infection Surveillance Solutions (Value)
      • 5.2.1. Global Infection Surveillance Solutions by: Type (Value)
        • 5.2.1.1. Software
        • 5.2.1.2. Services
      • 5.2.2. Global Infection Surveillance Solutions by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Long-term Care Facilities
        • 5.2.2.3. Others(Clinics, and Ambulatory Surgical Centers)
      • 5.2.3. Global Infection Surveillance Solutions by: Services (Value)
        • 5.2.3.1. Product Support & Maintenance Services
        • 5.2.3.2. Training & Consulting Services
        • 5.2.3.3. Implementation Services
      • 5.2.4. Global Infection Surveillance Solutions by: Software (Value)
        • 5.2.4.1. On-premise
        • 5.2.4.2. Web-based
      • 5.2.5. Global Infection Surveillance Solutions Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Infection Surveillance Solutions: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Premier Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Wolters Kluwer N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Baxter International Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GOJO Industries, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Atlas Medical Software (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Deb Group Ltd (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hygreen Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PointClickCare (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Inovalon (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Infection Surveillance Solutions Sale, by Type, Application, Services, Infection Type, Software and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Infection Surveillance Solutions (Value)
      • 7.2.1. Global Infection Surveillance Solutions by: Type (Value)
        • 7.2.1.1. Software
        • 7.2.1.2. Services
      • 7.2.2. Global Infection Surveillance Solutions by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Long-term Care Facilities
        • 7.2.2.3. Others(Clinics, and Ambulatory Surgical Centers)
      • 7.2.3. Global Infection Surveillance Solutions by: Services (Value)
        • 7.2.3.1. Product Support & Maintenance Services
        • 7.2.3.2. Training & Consulting Services
        • 7.2.3.3. Implementation Services
      • 7.2.4. Global Infection Surveillance Solutions by: Software (Value)
        • 7.2.4.1. On-premise
        • 7.2.4.2. Web-based
      • 7.2.5. Global Infection Surveillance Solutions Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Infection Surveillance Solutions: by Type(USD Million)
  • Table 2. Infection Surveillance Solutions Software , by Region USD Million (2015-2020)
  • Table 3. Infection Surveillance Solutions Services , by Region USD Million (2015-2020)
  • Table 4. Infection Surveillance Solutions: by Application(USD Million)
  • Table 5. Infection Surveillance Solutions Hospitals , by Region USD Million (2015-2020)
  • Table 6. Infection Surveillance Solutions Long-term Care Facilities , by Region USD Million (2015-2020)
  • Table 7. Infection Surveillance Solutions Others(Clinics, and Ambulatory Surgical Centers) , by Region USD Million (2015-2020)
  • Table 8. Infection Surveillance Solutions: by Services(USD Million)
  • Table 9. Infection Surveillance Solutions Product Support & Maintenance Services , by Region USD Million (2015-2020)
  • Table 10. Infection Surveillance Solutions Training & Consulting Services , by Region USD Million (2015-2020)
  • Table 11. Infection Surveillance Solutions Implementation Services , by Region USD Million (2015-2020)
  • Table 12. Infection Surveillance Solutions: by Software(USD Million)
  • Table 13. Infection Surveillance Solutions On-premise , by Region USD Million (2015-2020)
  • Table 14. Infection Surveillance Solutions Web-based , by Region USD Million (2015-2020)
  • Table 15. South America Infection Surveillance Solutions, by Country USD Million (2015-2020)
  • Table 16. South America Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 17. South America Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 18. South America Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 19. South America Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 20. South America Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 21. Brazil Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 22. Brazil Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 23. Brazil Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 24. Brazil Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 25. Brazil Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 26. Argentina Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 27. Argentina Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 28. Argentina Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 29. Argentina Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 30. Argentina Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 31. Rest of South America Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 32. Rest of South America Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 33. Rest of South America Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 34. Rest of South America Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 35. Rest of South America Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 36. Asia Pacific Infection Surveillance Solutions, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 40. Asia Pacific Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 41. Asia Pacific Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 42. China Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 43. China Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 44. China Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 45. China Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 46. China Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 47. Japan Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 48. Japan Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 49. Japan Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 50. Japan Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 51. Japan Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 52. India Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 53. India Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 54. India Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 55. India Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 56. India Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 57. South Korea Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 58. South Korea Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 59. South Korea Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 60. South Korea Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 61. South Korea Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 62. Taiwan Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 63. Taiwan Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 64. Taiwan Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 65. Taiwan Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 66. Taiwan Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 67. Australia Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 68. Australia Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 69. Australia Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 70. Australia Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 71. Australia Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 77. Europe Infection Surveillance Solutions, by Country USD Million (2015-2020)
  • Table 78. Europe Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 79. Europe Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 80. Europe Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 81. Europe Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 82. Europe Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 83. Germany Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 84. Germany Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 85. Germany Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 86. Germany Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 87. Germany Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 88. France Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 89. France Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 90. France Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 91. France Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 92. France Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 93. Italy Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 94. Italy Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 95. Italy Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 96. Italy Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 97. Italy Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 98. United Kingdom Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 99. United Kingdom Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 100. United Kingdom Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 101. United Kingdom Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 102. United Kingdom Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 103. Netherlands Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 104. Netherlands Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 105. Netherlands Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 106. Netherlands Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 107. Netherlands Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 108. Rest of Europe Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 109. Rest of Europe Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 110. Rest of Europe Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 111. Rest of Europe Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 112. Rest of Europe Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 113. MEA Infection Surveillance Solutions, by Country USD Million (2015-2020)
  • Table 114. MEA Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 115. MEA Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 116. MEA Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 117. MEA Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 118. MEA Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 119. Middle East Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 120. Middle East Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 121. Middle East Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 122. Middle East Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 123. Middle East Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 124. Africa Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 125. Africa Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 126. Africa Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 127. Africa Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 128. Africa Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 129. North America Infection Surveillance Solutions, by Country USD Million (2015-2020)
  • Table 130. North America Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 131. North America Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 132. North America Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 133. North America Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 134. North America Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 135. United States Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 136. United States Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 137. United States Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 138. United States Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 139. United States Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 140. Canada Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 141. Canada Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 142. Canada Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 143. Canada Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 144. Canada Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 145. Mexico Infection Surveillance Solutions, by Type USD Million (2015-2020)
  • Table 146. Mexico Infection Surveillance Solutions, by Application USD Million (2015-2020)
  • Table 147. Mexico Infection Surveillance Solutions, by Services USD Million (2015-2020)
  • Table 148. Mexico Infection Surveillance Solutions, by Infection Type USD Million (2015-2020)
  • Table 149. Mexico Infection Surveillance Solutions, by Software USD Million (2015-2020)
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Infection Surveillance Solutions: by Type(USD Million)
  • Table 161. Infection Surveillance Solutions Software , by Region USD Million (2021-2026)
  • Table 162. Infection Surveillance Solutions Services , by Region USD Million (2021-2026)
  • Table 163. Infection Surveillance Solutions: by Application(USD Million)
  • Table 164. Infection Surveillance Solutions Hospitals , by Region USD Million (2021-2026)
  • Table 165. Infection Surveillance Solutions Long-term Care Facilities , by Region USD Million (2021-2026)
  • Table 166. Infection Surveillance Solutions Others(Clinics, and Ambulatory Surgical Centers) , by Region USD Million (2021-2026)
  • Table 167. Infection Surveillance Solutions: by Services(USD Million)
  • Table 168. Infection Surveillance Solutions Product Support & Maintenance Services , by Region USD Million (2021-2026)
  • Table 169. Infection Surveillance Solutions Training & Consulting Services , by Region USD Million (2021-2026)
  • Table 170. Infection Surveillance Solutions Implementation Services , by Region USD Million (2021-2026)
  • Table 171. Infection Surveillance Solutions: by Software(USD Million)
  • Table 172. Infection Surveillance Solutions On-premise , by Region USD Million (2021-2026)
  • Table 173. Infection Surveillance Solutions Web-based , by Region USD Million (2021-2026)
  • Table 174. South America Infection Surveillance Solutions, by Country USD Million (2021-2026)
  • Table 175. South America Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 176. South America Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 177. South America Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 178. South America Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 179. South America Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 180. Brazil Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 181. Brazil Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 182. Brazil Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 183. Brazil Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 184. Brazil Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 185. Argentina Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 186. Argentina Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 187. Argentina Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 188. Argentina Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 189. Argentina Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 190. Rest of South America Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 191. Rest of South America Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 192. Rest of South America Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 193. Rest of South America Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 194. Rest of South America Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 195. Asia Pacific Infection Surveillance Solutions, by Country USD Million (2021-2026)
  • Table 196. Asia Pacific Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 197. Asia Pacific Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 198. Asia Pacific Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 199. Asia Pacific Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 200. Asia Pacific Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 201. China Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 202. China Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 203. China Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 204. China Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 205. China Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 206. Japan Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 207. Japan Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 208. Japan Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 209. Japan Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 210. Japan Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 211. India Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 212. India Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 213. India Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 214. India Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 215. India Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 216. South Korea Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 217. South Korea Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 218. South Korea Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 219. South Korea Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 220. South Korea Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 221. Taiwan Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 222. Taiwan Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 223. Taiwan Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 224. Taiwan Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 225. Taiwan Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 226. Australia Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 227. Australia Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 228. Australia Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 229. Australia Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 230. Australia Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 231. Rest of Asia-Pacific Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 232. Rest of Asia-Pacific Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 233. Rest of Asia-Pacific Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 234. Rest of Asia-Pacific Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 235. Rest of Asia-Pacific Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 236. Europe Infection Surveillance Solutions, by Country USD Million (2021-2026)
  • Table 237. Europe Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 238. Europe Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 239. Europe Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 240. Europe Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 241. Europe Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 242. Germany Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 243. Germany Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 244. Germany Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 245. Germany Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 246. Germany Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 247. France Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 248. France Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 249. France Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 250. France Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 251. France Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 252. Italy Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 253. Italy Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 254. Italy Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 255. Italy Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 256. Italy Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 257. United Kingdom Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 258. United Kingdom Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 259. United Kingdom Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 260. United Kingdom Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 261. United Kingdom Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 262. Netherlands Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 263. Netherlands Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 264. Netherlands Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 265. Netherlands Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 266. Netherlands Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 267. Rest of Europe Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 268. Rest of Europe Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 269. Rest of Europe Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 270. Rest of Europe Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 271. Rest of Europe Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 272. MEA Infection Surveillance Solutions, by Country USD Million (2021-2026)
  • Table 273. MEA Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 274. MEA Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 275. MEA Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 276. MEA Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 277. MEA Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 278. Middle East Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 279. Middle East Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 280. Middle East Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 281. Middle East Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 282. Middle East Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 283. Africa Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 284. Africa Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 285. Africa Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 286. Africa Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 287. Africa Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 288. North America Infection Surveillance Solutions, by Country USD Million (2021-2026)
  • Table 289. North America Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 290. North America Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 291. North America Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 292. North America Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 293. North America Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 294. United States Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 295. United States Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 296. United States Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 297. United States Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 298. United States Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 299. Canada Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 300. Canada Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 301. Canada Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 302. Canada Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 303. Canada Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 304. Mexico Infection Surveillance Solutions, by Type USD Million (2021-2026)
  • Table 305. Mexico Infection Surveillance Solutions, by Application USD Million (2021-2026)
  • Table 306. Mexico Infection Surveillance Solutions, by Services USD Million (2021-2026)
  • Table 307. Mexico Infection Surveillance Solutions, by Infection Type USD Million (2021-2026)
  • Table 308. Mexico Infection Surveillance Solutions, by Software USD Million (2021-2026)
  • Table 309. Research Programs/Design for This Report
  • Table 310. Key Data Information from Secondary Sources
  • Table 311. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Infection Surveillance Solutions: by Type USD Million (2015-2020)
  • Figure 5. Global Infection Surveillance Solutions: by Application USD Million (2015-2020)
  • Figure 6. Global Infection Surveillance Solutions: by Services USD Million (2015-2020)
  • Figure 7. Global Infection Surveillance Solutions: by Software USD Million (2015-2020)
  • Figure 8. South America Infection Surveillance Solutions Share (%), by Country
  • Figure 9. Asia Pacific Infection Surveillance Solutions Share (%), by Country
  • Figure 10. Europe Infection Surveillance Solutions Share (%), by Country
  • Figure 11. MEA Infection Surveillance Solutions Share (%), by Country
  • Figure 12. North America Infection Surveillance Solutions Share (%), by Country
  • Figure 13. Global Infection Surveillance Solutions share by Players 2020 (%)
  • Figure 14. Global Infection Surveillance Solutions share by Players (Top 3) 2020(%)
  • Figure 15. Global Infection Surveillance Solutions share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 19. Premier Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Premier Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Wolters Kluwer N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. Wolters Kluwer N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 23. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 25. GOJO Industries, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. GOJO Industries, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Atlas Medical Software (United States) Revenue, Net Income and Gross profit
  • Figure 28. Atlas Medical Software (United States) Revenue: by Geography 2020
  • Figure 29. Deb Group Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Deb Group Ltd (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Hygreen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Hygreen Inc. (United States) Revenue: by Geography 2020
  • Figure 33. PointClickCare (Canada) Revenue, Net Income and Gross profit
  • Figure 34. PointClickCare (Canada) Revenue: by Geography 2020
  • Figure 35. Inovalon (United States) Revenue, Net Income and Gross profit
  • Figure 36. Inovalon (United States) Revenue: by Geography 2020
  • Figure 37. Global Infection Surveillance Solutions: by Type USD Million (2021-2026)
  • Figure 38. Global Infection Surveillance Solutions: by Application USD Million (2021-2026)
  • Figure 39. Global Infection Surveillance Solutions: by Services USD Million (2021-2026)
  • Figure 40. Global Infection Surveillance Solutions: by Software USD Million (2021-2026)
  • Figure 41. South America Infection Surveillance Solutions Share (%), by Country
  • Figure 42. Asia Pacific Infection Surveillance Solutions Share (%), by Country
  • Figure 43. Europe Infection Surveillance Solutions Share (%), by Country
  • Figure 44. MEA Infection Surveillance Solutions Share (%), by Country
  • Figure 45. North America Infection Surveillance Solutions Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Premier Inc. (United States)
  • Wolters Kluwer N.V. (Netherlands)
  • Baxter International Inc. (United States)
  • GOJO Industries, Inc. (United States)
  • Atlas Medical Software (United States)
  • Deb Group Ltd (United Kingdom)
  • Hygreen Inc. (United States)
  • PointClickCare (Canada)
  • Inovalon (United States)
Additional players considered in the study are as follows:
TRUVEN Health Analytics (United States) , RL Solutions (Canada)
Select User Access Type

Key Highlights of Report


Oct 2021 227 Pages 93 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Infection Surveillance Solutions Quantitative research analysis
Global Infection Surveillance Solutions Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Infection Surveillance Solutions study can be customized to meet your requirements. The market size breakdown by type [Software and Services], by end use application [Hospitals, Long-term Care Facilities and Others(Clinics, and Ambulatory Surgical Centers)].
The Infection Surveillance Solutions Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Infection Surveillance Solutions market is expected to see growth rate of %.

Know More About Global Infection Surveillance Solutions Report?

Have a Query? Click Here

Other Related Reports

Artificial Disc Comprehensive Study by Type (Total Disc Replacement, Disc Nucleus Replacement), Application (Hospitals, Ambulatory Surgical Centres, Research Centres), Disc Type (Cervical Artificial ...
$ 3450
Dissolution Online Systems Comprehensive Study by Type (UV Online Systems, VIS Online Systems), Application (Pharmaceutical Industry, Chemical Industry, Laboratory Use, Others), Technology (Automated...
$ 3450
Dental CAD-CAM Comprehensive Study by Type (Practices CAD-CAM Systems, Laboratories CAD-CAM Systems), Application (Crowns, Inlays, Onlays, Veneers, Bridges, Dentures, Other Implant-Supported Restorat...
$ 3800
Zoonotic Disease Treatment Comprehensive Study by Diagnosis Method (Conventional Diagnosis (Microscopy, Antigen-Based Assays, Serological Assays), Metagenomics (Structural, and Functional)), Sales Ch...
$ 3750
Predictive Analytics in Healthcare Comprehensive Study by Application (Operations Management, Reporting & Compliance, Financial Data Analytics, Population Health, Clinical), Delivery Model (On-Premis...
$ 3650
Clinical Diagnostics Automation Comprehensive Study by Type (Modular Automation, Total Lab Automation), Application (Clinical Diagnostics, Drug Discovery, Proteomics Solutions, Others), Software (Aut...
$ 3650